EP05.02-002 Who Benefits More of Durvalumab after Chemoradiotherapy (CRT) in Real-World Patients with Locally Advanced Non-Small-Cell Lung Cancer (NSCLC)?

  1. Tavara, B.
  2. Garrido, M.L.
  3. Rodríguez, Z.
  4. Rojas, M.
  5. López, L.
  6. Medina, S.
  7. Ponte, C.
  8. Lopez, A.
  9. Sanchez, E.
  10. Pedraza, M.
  11. Viñals, P.
  12. López, M.
  13. Alonso, D.
  14. Rodríguez, A.
  15. Davila, E.
  16. Castañon, C.
  17. De Sande, L.M.
  18. Nieto, B.
  19. Vallejo Pascual, M.E. 1
  20. Rodríguez, J.d.l.R.
  21. Garcia Palomo, A.
  22. Diz Taín, P.
  1. 1 Universidad de León
    info

    Universidad de León

    León, España

    ROR https://ror.org/02tzt0b78

Revue:
Journal of Thoracic Oncology

ISSN: 1556-0864

Année de publication: 2022

Volumen: 17

Número: 9

Pages: S283

Type: Article

DOI: 10.1016/J.JTHO.2022.07.484 GOOGLE SCHOLAR lock_openAccès ouvert editor

D'autres publications dans: Journal of Thoracic Oncology